相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Lycopene in the Prevention of Cardiovascular Diseases
Sylwia Przybylska et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
PPAR Ligands Induce Antiviral Effects Targeting Perturbed Lipid Metabolism during SARS-CoV-2, HCV, and HCMV Infection
Marialuigia Fantacuzzi et al.
BIOLOGY-BASEL (2022)
Acacetin attenuates diabetes-induced cardiomyopathy by inhibiting oxidative stress and energy metabolism via PPAR-α/AMPK pathway
Fei Song et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2022)
Pretreatment of hydroethanolic extract of Dillenia indica L. attenuates oleic acid induced NAFLD in HepG2 cells via modulating SIRT-1/p-LKB-1/AMPK, HMGCR & PPAR-α signaling pathways
M. S. Poornima et al.
JOURNAL OF ETHNOPHARMACOLOGY (2022)
Ischemia-reperfusion damage is attenuated by GQ-11, a peroxisome proliferator-activated receptor (PPAR)-α/γ agonist, after aorta clamping in rats
Jacqueline Cavalcante Silva et al.
LIFE SCIENCES (2022)
DNA methylation of FTO promotes renal inflammation by enhancing m6A of PPAR-α in alcohol-induced kidney injury
Ju-Tao Yu et al.
PHARMACOLOGICAL RESEARCH (2021)
The Role of PPAR Alpha in the Modulation of Innate Immunity
Maja Grabacka et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Therapeutic Potential of Quercetin to Alleviate Endothelial Dysfunction in Age-Related Cardiovascular Diseases
Olina Dagher et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)
Curcumin, the golden spice in treating cardiovascular diseases
Hong Li et al.
BIOTECHNOLOGY ADVANCES (2020)
Legacy effect of fibrate add-on therapy in diabetic patients with dyslipidemia: a secondary analysis of the ACCORDION study
Lin Zhu et al.
CARDIOVASCULAR DIABETOLOGY (2020)
Glycyrrhiza glabra (Licorice) root extract attenuates doxorubicin-induced cardiotoxicity via alleviating oxidative stress and stabilising the cardiac health in H9c2 cardiomyocytes
Shishir Upadhyay et al.
JOURNAL OF ETHNOPHARMACOLOGY (2020)
Herbal Medicine for Cardiovascular Diseases: Efficacy, Mechanisms, and Safety
Abdullah Shaito et al.
FRONTIERS IN PHARMACOLOGY (2020)
The Novel Role of PPAR Alpha in the Brain: Promising Target in Therapy of Alzheimer's Disease and Other Neurodegenerative Disorders
Sylwia Wojtowicz et al.
NEUROCHEMICAL RESEARCH (2020)
The Role of Oxidative Stress in Cardiac Disease: From Physiological Response to Injury Factor
Rossella D'Oria et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2020)
Pleotropic Effects of Polyphenols in Cardiovascular System
Tapan Behl et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
The Effects of Linoleic Acid Consumption on Lipid Risk Markers for Cardiovascular Disease in Healthy Individuals: A Review of Human Intervention Trials
Erik Froyen et al.
NUTRIENTS (2020)
The Effects of Flavonoids in Cardiovascular Diseases
Lorena Ciumarnean et al.
MOLECULES (2020)
Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019 Update From the GBD 2019 Study
Gregory A. Roth et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Pemafibrate, a PPAR alpha agonist, attenuates neointima formation after vascular injury in mice fed normal chow and a high-fat diet
Tsuyoshi Horikawa et al.
HELIYON (2020)
Use of fenofibrate on cardiovascular outcomes in statin users with metabolic syndrome: propensity matched cohort study
Nam Hoon Kim et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
The Global Burden of Cardiovascular Diseases and Risk Factors 2020 and Beyond
George A. Mensah et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Oxidative Stress in Cardiovascular Diseases: Still a Therapeutic Target?
Thomas Senoner et al.
NUTRIENTS (2019)
NUtraceutical TReatment for hYpercholesterolemia in HIV-infected patients: The NU-TRY(HIV) randomized cross- over trial
Matteo Pirro et al.
ATHEROSCLEROSIS (2019)
LncRNA MEG8 regulates vascular smooth muscle cell proliferation, migration and apoptosis by targeting PPARα
Boya Zhang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
Ginsenoside Rb3 regulates energy metabolism and apoptosis in cardiomyocytes via activating PPARα pathway
Xu Chen et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
The microRNAs Regulating Vascular Smooth Muscle Cell Proliferation: A Minireview
Dongdong Wang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Modulation of NFKB1/p50 by ROS leads to impaired ATP production during MI compared to cardiac hypertrophy
Arkadeep Mitra et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
Extra Virgin Olive Oil and Cardiovascular Diseases: Benefits for Human Health
Cristina Nocella et al.
ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS (2018)
Vascular smooth muscle cell proliferation as a therapeutic target. Part 2: Natural products inhibiting proliferation
Pavel Uhrin et al.
BIOTECHNOLOGY ADVANCES (2018)
Spotlight on small molecules in cardiovascular diseases
Xin Wang et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Effects of Pemafibrate, a Novel Selective PPAR alpha Modulator, on Lipid and Glucose Metabolism in Patients With Type 2 Diabetes and Hypertriglyceridemia: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial
Eiichi Araki et al.
DIABETES CARE (2018)
Molecular Actions of PPARα in Lipid Metabolism and Inflammation
Nadia Bougarne et al.
ENDOCRINE REVIEWS (2018)
PPAR Agonists and Metabolic Syndrome: An Established Role?
Margherita Botta et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
PPARα activation alleviates damage to the cytoskeleton during acute myocardial ischemia/reperfusion in rats
Jie Yuan et al.
MOLECULAR MEDICINE REPORTS (2018)
Targeting activator protein 1 signaling pathway by bioactive natural agents: Possible therapeutic strategy for cancer prevention and intervention
Devesh Tewari et al.
PHARMACOLOGICAL RESEARCH (2018)
Correlation between PPAR-α methylation level in peripheral blood and atherosclerosis of NAFLD patients with DM
Jianghua Ju et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2018)
Anti-hypertensive and cardioprotective effects of a novel apitherapy formulation via upregulation of peroxisome proliferator-activated receptor-α and -γ in spontaneous hypertensive rats
Yanru Sun et al.
SAUDI JOURNAL OF BIOLOGICAL SCIENCES (2018)
Statin dose reduction with complementary diet therapy: A pilot study of personalized medicine
Bianca Scolaro et al.
MOLECULAR METABOLISM (2018)
The nuclear receptor superfamily: A structural perspective
Emily R. Weikum et al.
PROTEIN SCIENCE (2018)
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
G. G. Schwartz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
The Pioglitazone Trek via Human PPAR Gamma: From Discovery to a Medicine at the FDA and Beyond
Pallavi R. Devchand et al.
FRONTIERS IN PHARMACOLOGY (2018)
Endothelial permeability, LDL deposition, and cardiovascular risk factors-a review
Santa Mundi et al.
CARDIOVASCULAR RESEARCH (2018)
Polyphenol intake from a Mediterranean diet decreases inflammatory biomarkers related to atherosclerosis: a substudy of the PREDIMED trial
Alexander Medina-Remon et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2017)
Dietary polyphenols are inversely associated with metabolic syndrome in Polish adults of the HAPIEE study
Giuseppe Grosso et al.
EUROPEAN JOURNAL OF NUTRITION (2017)
PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD
Barbara Gross et al.
NATURE REVIEWS ENDOCRINOLOGY (2017)
Effect of berberine on PPAR(alpha)-NO signalling pathway in vascular smooth muscle cell proliferation induced by angiotensin IV
Hongmei Qiu et al.
PHARMACEUTICAL BIOLOGY (2017)
Nutritionally relevant concentrations of resveratrol and hydroxytyrosol mitigate oxidative burst of human granulocytes and monocytes and the production of pro-inflammatory mediators in LPS-stimulated RAW 264.7 macrophages
Elisabetta Bigagli et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2017)
The Pharmacological Potential of Rutin
Aditya Ganeshpurkar et al.
SAUDI PHARMACEUTICAL JOURNAL (2017)
Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trial
Marc S. Sabatine et al.
LANCET DIABETES & ENDOCRINOLOGY (2017)
Green tea polyphenol treatment attenuates atherosclerosis in high-fat diet-fed apolipoprotein E-knockout mice via alleviating dyslipidemia and up-regulating autophagy
Shibin Ding et al.
PLOS ONE (2017)
PPARα Agonist Stimulated Angiogenesis by Improving Endothelial Precursor Cell Function Via a NLRP3 Inflammasome Pathway
Yaping Deng et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Peroxisome proliferator-activated receptors as therapeutic targets for heart failure
Abdelrahman Ibrahim Abushouka et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Metabolic reprogramming via PPARα signaling in cardiac hypertrophy and failure: From metabolomics to epigenetics
Junco Shibayama Warren et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2017)
PPARs and nonalcoholic fatty liver disease
Kim H. H. Liss et al.
BIOCHIMIE (2017)
PPARs: regulators of metabolism and as therapeutic targets in cardiovascular disease. Part I: PPAR-α
Lu Han et al.
FUTURE CARDIOLOGY (2017)
Activation of PPAR-α in the early stage of heart failure maintained myocardial function and energetics in pressure-overload heart failure
Satoshi Kaimoto et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2017)
The role of nutraceuticals in the prevention of cardiovascular disease
Bozena Sosnowska et al.
CARDIOVASCULAR DIAGNOSIS AND THERAPY (2017)
Sulforaphane prevents rat cardiomyocytes from hypoxia/reoxygenation injury in vitro via activating SIRT1 and subsequently inhibiting ER stress
Yun-peng Li et al.
ACTA PHARMACOLOGICA SINICA (2016)
Aleglitazar, a Balanced Dual PPARα and -γ Agonist, Protects the Heart Against Ischemia-Reperfusion Injury
Jinqiao Qian et al.
CARDIOVASCULAR DRUGS AND THERAPY (2016)
Role of Pleiotropic Properties of Peroxisome Proliferator-Activated Receptors in the Heart: Focus on the Nonmetabolic Effects in Cardiac Protection
Eleftheria Barlaka et al.
CARDIOVASCULAR THERAPEUTICS (2016)
Inhibition of Cardiomyocytes Hypertrophy by Resveratrol Is Associated with Amelioration of Endoplasmic Reticulum Stress
Yan Lin et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2016)
New Role of Hispidulin in Lipid Metabolism: PPARα Activator
Xinchi Wu et al.
LIPIDS (2016)
Occurrence of non-heterocyclic resveratrol tetramer in Vatica chinensis
Tetsuro Ito et al.
PHYTOCHEMISTRY LETTERS (2016)
The efficacy and safety of Fufangdanshen tablets (Radix Salviae miltiorrhizae formula tablets) for mild to moderate vascular dementia: a study protocol for a randomized controlled trial
Jinzhou Tian et al.
TRIALS (2016)
Fibrates for primary prevention of cardiovascular disease events
Tobias Jakob et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2016)
A green tea-containing starch confection increases plasma catechins without protecting against postprandial impairments in vascular function in normoglycemic adults
Teryn N. Sapper et al.
FOOD & FUNCTION (2016)
Preclinical and clinical evidence for the role of resveratrol in the treatment of cardiovascular diseases
Beshay N. M. Zordoky et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2015)
Activation of Peroxisome Proliferator-Activated Receptor gamma (PPAR gamma) Through NF-kappa B/Brg1 and TGF-beta(1) Pathways Attenuates Cardiac Remodeling in Pressure-Overloaded Rat Hearts
Han-Ping Qi et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2015)
Effect of Salusin-β on Peroxisome Proliferator-Activated Receptor Gamma Gene Expression in Vascular Smooth Muscle Cells and its Possible Mechanism
XiaoLe Xu et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2015)
Marked antioxidant effect of orange juice intake and its phytomicronutrients in a preliminary randomized cross-over trial on mild hypercholesterolemic men
Joel Constans et al.
CLINICAL NUTRITION (2015)
Activation of PPAR alpha by fenofibrate inhibits apoptosis in vascular adventitial fibroblasts partly through SIRT1-mediated deacetylation of FoxO1
Wei-rong Wang et al.
EXPERIMENTAL CELL RESEARCH (2015)
Sulforaphane Protects against Cardiovascular Disease via Nrf2 Activation
Yang Bai et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2015)
A standardized notoginseng extract exerts cardioprotection by attenuating apoptosis under endoplasmic reticulum stress conditions
Li-Chao Wang et al.
JOURNAL OF FUNCTIONAL FOODS (2015)
Fibrates for secondary prevention of cardiovascular disease and stroke
D. Wang et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2015)
Marine Bioactive Compounds and Their Health Benefits: A Review
Imen Hamed et al.
COMPREHENSIVE REVIEWS IN FOOD SCIENCE AND FOOD SAFETY (2015)
PPARα ligand clofibrate ameliorates blood pressure and vascular reactivity in spontaneously hypertensive rats
Zivar Yousefipour et al.
ACTA PHARMACOLOGICA SINICA (2014)
Natural product agonists of peroxisome proliferator-activated receptor gamma (PPAR-γ): a review
Limei Wang et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Quercetin, luteolin and epigallocatechin gallate alleviate TXNIP and NLRP3-mediated inflammation and apoptosis with regulation of AMPK in endothelial cells
Jianjun Wu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
Linalool is a PPARα ligand that reduces plasma TG levels and rewires the hepatic transcriptome and plasma metabolome
Hee-jin Jun et al.
JOURNAL OF LIPID RESEARCH (2014)
Maslinic acid protects vascular smooth muscle cells from oxidative stress through Akt/Nrf2/HO-1 pathway
Xiaofei Qin et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2014)
Cardiomyocyte specific peroxisome proliferator-activated receptor-α overexpression leads to irreversible damage in ischemic murine heart
Georg D. Duerr et al.
LIFE SCIENCES (2014)
Icariin Is A PPARα Activator Inducing Lipid Metabolic Gene Expression in Mice
Yuan-Fu Lu et al.
MOLECULES (2014)
Pharmaceutically active secondary metabolites of marine actinobacteria
Panchanathan Manivasagan et al.
MICROBIOLOGICAL RESEARCH (2014)
Oxymatrine attenuates hepatic steatosis in non-alcoholic fatty liver disease rats fed with high fructose diet through inhibition of sterol regulatory element binding transcription factor 1(Srebf1) and activation of peroxisome proliferator activated receptor alpha (Ppar alpha)
Li-juan Shi et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
Effect of Berberine on PPARα/NO Activation in High Glucose- and Insulin-Induced Cardiomyocyte Hypertrophy
Mingfeng Wang et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2013)
Association of Peroxisome Proliferator-Activated Receptor γ Polymorphisms and Haplotypes with Essential Hypertension
Shu-Jun Gu et al.
GENETIC TESTING AND MOLECULAR BIOMARKERS (2013)
Fenofibrate lowers blood pressure in salt-sensitive but not salt-resistant hypertension
Kimberly Gilbert et al.
JOURNAL OF HYPERTENSION (2013)
Dill seed extract improves abnormalities in lipid metabolism through peroxisome proliferator-activated receptor-α (PPAR-α) activation in diabetic obese mice
Nobuyuki Takahashi et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2013)
Quercetin and quercetin-3-O-glucuronide are equally effective in ameliorating endothelial insulin resistance through inhibition of reactive oxygen species-associated inflammation
Xu-Dan Guo et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2013)
PPARγ signaling and metabolism: the good, the bad and the future
Maryam Ahmadian et al.
NATURE MEDICINE (2013)
The effects of fenofibrate on inflammation and cardiovascular markers in patients with active rheumatoid arthritis: a pilot study
Ivan Shirinsky et al.
RHEUMATOLOGY INTERNATIONAL (2013)
PANAX QUINQUEFOLIUM SAPONIN ATTENUATES VENTRICULAR REMODELING AFTER ACUTE MYOCARDIAL INFARCTION BY INHIBITING CHOP-MEDIATED APOPTOSIS
Mi Liu et al.
SHOCK (2013)
Bilobetin ameliorates insulin resistance by PKA-mediated phosphorylation of PPARa in rats fed a high-fat diet
Xin-Hui Kou et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Targeting Peroxisome Proliferator-Activated Receptors (PPARs): Development of Modulators
Celine Pirat et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
The intestinal bioavailability of vaccenic acid and activation of peroxisome proliferator-activated receptor-α and -γ in a rodent model of dyslipidemia and the metabolic syndrome
Ye Wang et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2012)
The natural carotenoid astaxanthin, a PPAR-α agonist and PPAR-γ antagonist, reduces hepatic lipid accumulation by rewiring the transcriptome in lipid-loaded hepatocytes
Yaoyao Jia et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2012)
Efficacy of fibrates for cardiovascular risk reduction in persons with atherogenic dyslipidemia: A meta-analysis
Meng Lee et al.
ATHEROSCLEROSIS (2011)
Luteolin inhibits inflammatory response and improves insulin sensitivity in the endothelium
Zhu Deqiu et al.
BIOCHIMIE (2011)
Sirt1 acts in association with PPARα to protect the heart from hypertrophy, metabolic dysregulation, and inflammation
Ana Planavila et al.
CARDIOVASCULAR RESEARCH (2011)
The PPAR-RXR Transcriptional Complex in the Vasculature Energy in the Balance
Jorge Plutzky
CIRCULATION RESEARCH (2011)
Decrease of Blood Lipids Induced by Shan-Zha (Fruit of Crataegus pinnatifida) is Mainly Related to an Increase of PPARα in Liver of Mice Fed High-Fat Diet
C. -S. Niu et al.
HORMONE AND METABOLIC RESEARCH (2011)
Effect of Curcumin on LDL Oxidation in Vitro, and Lipid Peroxidation and Antioxidant Enzymes in Cholesterol Fed Rabbits
Mohamedain M. Mahfouz et al.
INTERNATIONAL JOURNAL FOR VITAMIN AND NUTRITION RESEARCH (2011)
Association of the peroxisome proliferator-activated receptor α gene L162V polymorphism with stage C heart failure
Teresa Arias et al.
JOURNAL OF HYPERTENSION (2011)
9-oxo-10(E), 12(E)-octadecadienoic acid derived from tomato is a potent PPAR α agonist to decrease triglyceride accumulation in mouse primary hepatocytes
Young-Il Kim et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2011)
Antihyperglycemic and Antihyperlipidemic Action of Cinnamomi Cassiae (Cinnamon Bark) Extract in C57BL/Ks db/db Mice
Sung Hee Kim et al.
ARCHIVES OF PHARMACAL RESEARCH (2010)
Yamabushitake Mushroom (Hericium erinaceus) Improved Lipid Metabolism in Mice Fed a High-Fat Diet
Kazuyuki Hiwatashi et al.
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2010)
Fucoxanthin supplementation improves plasma and hepatic lipid metabolism and blood glucose concentration in high-fat fed C57BL/6N mice
Myoung-Nam Woo et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2010)
PPARα stimulation exerts a blood pressure lowering effect through different mechanisms in a time-dependent manner
Luz Ibarra-Lara et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
Whole Grape Intake Impacts Cardiac Peroxisome Proliferator-Activated Receptor and Nuclear Factor κB Activity and Cytokine Expression in Rats With Diastolic Dysfunction
E. Mitchell Seymour et al.
HYPERTENSION (2010)
Vaticanol C, a resveratrol tetramer, activates PPARα and PPARβ/δ in vitro and in vivo
Tomoko Tsukamoto et al.
NUTRITION & METABOLISM (2010)
The peroxisome proliferator-activated receptor-α (PPAR-α) agonist, AVE8134, attenuates the progression of heart failure and increases survival in rats
Wolfgang Linz et al.
ACTA PHARMACOLOGICA SINICA (2009)
PPAR-α activation protects the type 2 diabetic myocardium against ischemia-reperfusion injury: involvement of the PI3-Kinase/Akt and NO pathway
Aliaksandr A. Bulhak et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2009)
PPARs and the Cardiovascular System
Milton Hamblin et al.
ANTIOXIDANTS & REDOX SIGNALING (2009)
Adrenal androgen dehydroepiandrosterone sulfate inhibits vascular remodeling following arterial injury
Masaaki Ii et al.
ATHEROSCLEROSIS (2009)
The dual PPARα/γ agonist tesaglitazar blocks progression of pre-existing atherosclerosis in APOE*3Leiden.CETP transgenic mice
J. W. A. van der Hoorn et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Peroxisome Proliferator-Activated Receptor γ and Cardiovascular Diseases
Hiroyuki Takano et al.
CIRCULATION JOURNAL (2009)
Naringenin Prevents Dyslipidemia, Apolipoprotein B Overproduction, and Hyperinsulinemia in LDL Receptor-Null Mice With Diet-Induced Insulin Resistance
Erin E. Mulvihill et al.
DIABETES (2009)
Efficacy and safety of ginsenoside-Rd for acute ischaemic stroke: a randomized, double-blind, placebo-controlled, phase II multicenter trial
X. Liu et al.
EUROPEAN JOURNAL OF NEUROLOGY (2009)
Activation of PPAR γ and α by Punicic Acid Ameliorates Glucose Tolerance and Suppresses Obesity-Related Inflammation
Raquel Hontecillas et al.
JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION (2009)
PPAR-alpha agonist fenofibrate induces renal CYP enzymes and reduces blood pressure and glomerular hypertrophy in Zucker diabetic fatty rats
Xueying Zhao et al.
AMERICAN JOURNAL OF NEPHROLOGY (2008)
Auraptene, a citrus fruit compound, regulates gene expression as a PPAR alpha agonist in HepG2 hepatocytes
Nobuyuki Takahashi et al.
BIOFACTORS (2008)
The PPARα/p16INK4a Pathway Inhibits Vascular Smooth Muscle Cell Proliferation by Repressing Cell Cycle-Dependent Telomerase Activation
Florence Gizard et al.
CIRCULATION RESEARCH (2008)
Catalpic acid decreases abdominal fat deposition, improves glucose homeostasis and upregulates PPAR alpha expression in adipose tissue
Raquel Hontecillas et al.
CLINICAL NUTRITION (2008)
Peroxisome proliferator-activated receptor α activation attenuated angiotensin type 1-mediated but enhanced angiotensin type 2-mediated hemodynamic effects to angiotensin II in the rat
Tina Banks et al.
JOURNAL OF HYPERTENSION (2008)
Colfibrate attenuates blood pressure and sodium retention in DOCA-salt hypertension
Yiqiang Zhou et al.
KIDNEY INTERNATIONAL (2008)
Farnesol decreases serum triglycerides in rats:: Identification of mechanisms including up-regulation of PPARα and down-regulation of fatty acid synthase in hepatocytes
Robin E. Duncan et al.
LIPIDS (2008)
Platelet function in intravascular device implant-induced intimal injury
Belay Tesfamariam
CARDIOVASCULAR REVASCULARIZATION MEDICINE (2008)
Tesaglitazar, a dual peroxisome proliferator-activated receptor alpha/gamma agonist, reduces atherosclerosis in female low density lipoprotein receptor deficient mice
Ebele C. Chira et al.
ATHEROSCLEROSIS (2007)
Macrophage expression of peroxisome proliferator-activated receptor-α reduces atherosclerosis in low-density lipoprotein receptor-deficient mice
Vladimir R. Babaev et al.
CIRCULATION (2007)
Modulation of PPAR activity via phosphorylation
Katherine A. Burns et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2007)
Inhibition of smooth muscle proliferation by urea-based alkanoic acids via peroxisome proliferator-activated receptor α-dependent repression of cyclin D1
Valerie Y. Ng et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications
Rhian M. Touyz et al.
VASCULAR PHARMACOLOGY (2006)
Protection against myocardial ischaemia/reperfusion injury by PPAR-α activation is related to production of nitric oxide and endothelin-1
A Bulhak et al.
BASIC RESEARCH IN CARDIOLOGY (2006)
Peroxisome proliferator-activated receptor alpha agonist, clofibrate, has profound influence on myocardial fatty acid composition
Q Tian et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2006)
Chronic activation of PPAR alpha is detrimental to cardiac recovery after ischemia
N Sambandam et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Peroxisome proliferator-activated receptors and inflammation
Leonardo A. Moraes et al.
PHARMACOLOGY & THERAPEUTICS (2006)
NAD(P)H oxidase/nitric oxide interactions in peroxisome proliferator activated receptor (PPAR)α-mediated cardiovascular effects
M Newaz et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2005)
PPARα inhibits vascular smooth muscle cell proliferation underlying intimal hyperplasia by inducing the tumor suppressor p16INK4a
F Gizard et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Isohumulones modulate blood lipid status through the activation of PPARα
M Shimura et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2005)
PPARα, but not PPARγ, activators decrease macrophage-laden atherosclerotic lesions in a nondiabetic mouse model of mixed dyslipidemia
N Hennuyer et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Downregulation of peroxisome proliferator-activated receptor-α gene expression in a mouse model of ischemic cardiomyopathy is dependent on reactive oxygen species and prevents lipotoxicity
O Dewald et al.
CIRCULATION (2005)
Additive beneficial effects of fenofibrate combined with atorvastatin in the treatment of combined hyperlipidemia
KK Koh et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Peroxisome proliferator-activated receptor-alpha and atherosclerosis: From basic mechanisms to clinical implications
Z Israelian-Konaraki et al.
CARDIOLOGY (2005)
Cardiovascular disease: Different strategies for primary and secondary prevention?
FDR Hobbs
HEART (2004)
Association between the PPARα L162V polymorphism, plasma lipoprotein levels, and atherosclerotic disease in patients with diabetes mellitus type 2 and in nondiabetic controls
I Gouni-Berthold et al.
AMERICAN HEART JOURNAL (2004)
Genistein enhances expression of genes involved in fatty acid catabolism through activation of PPARα
S Kim et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2004)
Differential effects of green tea-derived catechin on developing versus established atherosclerosis in apolipoprotein E-null mice
KY Chyu et al.
CIRCULATION (2004)
Peroxisome proliferator-activated receptor-α and receptor-γ activators prevent cardiac fibrosis in mineralocorticoid-dependent hypertension
M Iglarz et al.
HYPERTENSION (2003)
Peroxisome proliferator-activated receptor-alpha and receptor-gamma activators prevent cardiac fibrosis in mineralocorticoid-dependent hypertension
M Iglarz et al.
HYPERTENSION (2003)
The human apolipoprotein AV gene is regulated by peroxisome proliferator-activated receptor-α and contains a novel farnesoid X-activated receptor response element
X Prieur et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Peroxisome proliferator-activated receptor-α agonist treatment in a transgenic model of type 2 diabetes reverses the lipotoxic state and improves glucose homeostasis
H Kim et al.
DIABETES (2003)
PPAR-α effects on the heart and other vascular tissues
GA Francis et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2003)
Cholesterol-lowering effect of a theaflavin-enriched green tea extract - A randomized controlled trial
DJ Maron et al.
ARCHIVES OF INTERNAL MEDICINE (2003)
Effect of peroxisome proliferator-activated receptor-alpha and -gamma activators on vascular remodeling in endothelin-dependent hypertension
M Iglarz et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Bitter gourd (Momordica charantia) extract activates peroxisome proliferator-activated receptors and upregulates the expression of the acyl CoA oxidase gene in H4IIEC3 hepatoma cells
CY Chao et al.
JOURNAL OF BIOMEDICAL SCIENCE (2003)
Reduction of atherosclerosis by the peroxisome proliferator-activated receptor α agonist fenofibrate in mice
H Duez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Lycopene, tomatoes, and the prevention of coronary heart disease
AV Rao
EXPERIMENTAL BIOLOGY AND MEDICINE (2002)
Peroxisome proliferator-activated receptor agonists, hyperlipidaemia, and atherosclerosis
H Vosper et al.
PHARMACOLOGY & THERAPEUTICS (2002)
Peroxisome proliferator-activated receptor α gene variants influence progression of coronary atherosclerosis and risk of coronary artery disease
DM Flavell et al.
CIRCULATION (2002)
The peroxisome proliferator-activated receptor α regulates amino acid metabolism
S Kersten et al.
FASEB JOURNAL (2001)
Relation of gemfibrozil treatment and lipid levels with major coronary events - VA-HIT: A randomized controlled trial
SJ Robins et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Peroxisome proliferator-activated receptor (PPAR)-α activation lowers muscle lipids and improves insulin sensitivity in high fat-fed rats -: Comparison with PPAR-γ activation
JM Ye et al.
DIABETES (2001)
分享论文
